Variants of Concern

Study measures vaccine effectiveness against Omicron infection in Ontario

In a not yet peer-reviewed pre-print study led by CITF-funded researcher Dr. Jeff Kwong on behalf of the Canadian Immunization Research Network (CIRN), researchers evaluated the effectiveness of mRNA (or combined mRNA and AstraZeneca’s Vaxzevria) vaccines in preventing symptomatic infection and severe outcomes caused by the Omicron variant in Ontario.

2022-05-03T11:41:55-04:00February 7, 2022|Variants of Concern|
Go to Top